Pharmaessentia selects veeva data cloud to support launch of novel therapy for rare, chronic blood cancers

Pleasanton, calif., dec. 14, 2021 /prnewswire/ -- veeva systems (nyse: veev) today announced that pharmaessentia has adopted veeva data cloud to support the launch of besremi, a new therapy for polycythemia vera (pv), a rare blood cancer.
VEEV Ratings Summary
VEEV Quant Ranking